Cardiotoxicity: precision medicine with imprecise definitions

Affiliations

¹ Hatter Cardiovascular Institute, University College London, London, UK.
² Barts Heart Centre, Barts Health NHS Trust, London, UK.
³ Farr Institute of Health Informatics Research, University College London, London, UK.

Editorial

Robin Chung et al. Open Heart. 2018.

. 2018 Jul 25;5(2):e000774.

doi: 10.1136/openhrt-2018-000774. eCollection 2018.

¹ Hatter Cardiovascular Institute, University College London, London, UK.
² Barts Heart Centre, Barts Health NHS Trust, London, UK.
³ Farr Institute of Health Informatics Research, University College London, London, UK.

No abstract available

Keywords: anthracycline cardiotoxicity; chemotherapy; malignency; systolic heart failure.

Conflict of interest statement

Competing interests: None declared.

1. DeSantis CE, Lin CC, Mariotto AB, et al. . Cancer treatment and survivorship statistics, 2014. CA Cancer J Clin 2014;64:252–71. 10.3322/caac.21235 - DOI - PubMed
1. Maddams J, Utley M, Møller H. Projections of cancer prevalence in the United Kingdom, 2010-2040. Br J Cancer 2012;107:1195–202. 10.1038/bjc.2012.366 - DOI - PMC - PubMed
1. Schwaederle M, Zhao M, Lee JJ, et al. . Association of biomarker-based treatment strategies with response rates and progression-free survival in refractory malignant neoplasms: a meta-analysis. JAMA Oncol 2016;2:1452–9. 10.1001/jamaoncol.2016.2129 - DOI - PubMed
1. National Cancer Institute Dictionary of Cancer Terms. Precision medicine. 2018. https://www.cancer.gov/publications/dictionaries/cancer-terms/def/precis...
1. Thavendiranathan P, Grant AD, Negishi T, et al. . Reproducibility of echocardiographic techniques for sequential assessment of left ventricular ejection fraction and volumes: application to patients undergoing cancer chemotherapy. J Am Coll Cardiol 2013;61:77–84. 10.1016/j.jacc.2012.09.035 - DOI - PubMed